Overview

Evans Baroque is a leading pharmaceutical healthcare company with global partnerships and a vast presence in West Africa. The brand has advanced technological capabilities, through its recent acquisition of world-class WHO-GMP compliant pharmaceutical manufacturing facilities based in Agbara, Ogun State, Nigeria. EB has an annual capacity of 4.5 billion Tablets, 270 million capsules, 24 million litres of liquid formulation, creams & ointments and 3000MT of nutraceutical powders. Rich Heritage and culture - Evans Baroque has evolved from strategic collaborations with Miral Pharmaceuticals, an established pharma product design and marketing company; Baroque, an Indian-based pharmaceutical company and Iroko Capital, a Lagos-based investment banking, asset management and principal investing firm. In 2018, Miral & Baroque, through jointly acquiring the manufacturing facilities of Evans Medical Plc (formerly Glaxo), evolved as the existing pharmaceutical conglomerate EVANS BAROQUE LTD. Inheriting a strong lineage from two of the most successful pharmaceutical cultures, EB creates a unique synergy of marketing, manufacturing, sales, and distribution. Healthcare Range- EB offers one the most comprehensive range of pharmaceuticals and healthcare brands, under its OTC and Prescription Medicines category, catering across different demographics: Family Care, Men’s Care, Women’s Care, and Kids’ Care. The brand also offers a wide range of therapeutic medicines among every critical segment which includes; antibiotics, antimalarial, analgesic, anti-inflammatory, hematinic, supplements, anti-hypertensive, medical/surgical consumables, hand sanitizers and healthcare kits. EB is proud to highlight it's WHO-GMP (one of the four plants in Nigeria) compliant pharmaceutical facilities sitting on 8.3 hectares of land located in Agbara. 1. Pharma Plant I, II & III dedicated to different formulation. wwe.evansbaroque.com